I am a board-certified endocrinologist with a focus in thyroid cancer based at Memorial Sloan Kettering Cancer Center (MSKCC) in New York where I hold a position of Professor of Clinical Medicine. Nationally, I served as committee member for the American Thyroid Association Patient Education and Advocacy committee (2008-2014) and Chair and member of the Clinical Affairs committee ( 2011-2017). I serve currently as the co-Chair of the 2019 ATA Program committee and remain an active member of ATA and the Endocrine Society. My research was centered on quantifying clinical response to radioactive iodine therapy in patients with metastatic thyroid cancer and correlating this response to specific clinical and genotypic presentations. My recent studies focused on the relationship between tumor growth rate and overall survival from progressive metastatic thyroid cancer in addition to assessing clinical response to molecular targeted therapy and its effects on patients’ disease specific survival.